These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 22499291

  • 1. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment.
    Mancia G, Facchetti R, Parati G, Zanchetti A.
    J Hypertens; 2012 Jun; 30(6):1241-51. PubMed ID: 22499291
    [Abstract] [Full Text] [Related]

  • 2. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis.
    Mancia G, Parati G, Bilo G, Maronati A, Omboni S, Baurecht H, Hennig M, Zanchetti A.
    J Hypertens; 2007 May; 25(5):1087-94. PubMed ID: 17414674
    [Abstract] [Full Text] [Related]

  • 3. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.
    Mancia G, Facchetti R, Parati G, Zanchetti A.
    Circulation; 2012 Jul 31; 126(5):569-78. PubMed ID: 22761453
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.
    Zanchetti A, Hennig M, Baurecht H, Tang R, Cuspidi C, Carugo S, Mancia G.
    J Hypertens; 2007 Dec 31; 25(12):2463-70. PubMed ID: 17984668
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 31; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul 31; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 31; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The preliminary clinical evidence from the ELSA study. The European Lacidipine Study on Atherosclerosis].
    Leonetti G.
    Ann Ital Med Int; 1995 Oct 31; 10 Suppl():74S-77S. PubMed ID: 8562272
    [Abstract] [Full Text] [Related]

  • 14. [Modeling of systolic blood pressure reaction to antihypertensive agents in people with hypertension].
    Wu Y, Li YS, Bejan-Angoulvant T, Gueyffier F.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr 31; 39(4):309-14. PubMed ID: 21624305
    [Abstract] [Full Text] [Related]

  • 15. Additive hypotensive effect of a dihydropyridine calcium antagonist to that produced by a thiazide diuretic: a double-blind placebo-controlled crossover trial with ambulatory blood pressure monitoring.
    Stergiou GS, Malakos JS, Achimastos AD, Mountokalakis TD.
    J Cardiovasc Pharmacol; 1997 Mar 31; 29(3):412-6. PubMed ID: 9125681
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 31; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 18. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA).
    Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, Costa B, Scherz R, Bond G, Zanchetti A, ELSA Investigators.
    J Hypertens; 2001 Nov 31; 19(11):1981-9. PubMed ID: 11677363
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
    J Hum Hypertens; 2004 Mar 31; 18(3):215-22. PubMed ID: 14973517
    [Abstract] [Full Text] [Related]

  • 20. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug 31; 25(8):710-4. PubMed ID: 15555399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.